Amanda M. Li

2.6k total citations
14 papers, 387 citations indexed

About

Amanda M. Li is a scholar working on Oncology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Amanda M. Li has authored 14 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Amanda M. Li's work include CAR-T cell therapy research (4 papers), Acute Lymphoblastic Leukemia research (3 papers) and Immune Cell Function and Interaction (2 papers). Amanda M. Li is often cited by papers focused on CAR-T cell therapy research (4 papers), Acute Lymphoblastic Leukemia research (3 papers) and Immune Cell Function and Interaction (2 papers). Amanda M. Li collaborates with scholars based in Canada, United States and Israel. Amanda M. Li's co-authors include Michael A. Sargent, Brian A. Lupton, Vann Chau, Elke H. Roland, Kenneth J. Poskitt, Alan Hill, Steven P. Miller, Colleen Callahan, David T. Teachey and Vanessa Gonzalez and has published in prestigious journals such as Blood, Cancer and Journal of Neurophysiology.

In The Last Decade

Amanda M. Li

13 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amanda M. Li Canada	9	159	98	82	58	56	14	387
Anuradha Krishnamurthy United States	12	245 1.5×	72 0.7×	131 1.6×	45 0.8×	16 0.3×	25	575
Scott Paterson Australia	14	120 0.8×	44 0.4×	260 3.2×	60 1.0×	24 0.4×	17	489
Guido Lancman United States	15	249 1.6×	82 0.8×	168 2.0×	14 0.2×	39 0.7×	44	693
Olga Dratviman‐Storobinsky Israel	15	63 0.4×	58 0.6×	214 2.6×	28 0.5×	82 1.5×	31	509
Li Cui China	9	27 0.2×	51 0.5×	62 0.8×	31 0.5×	23 0.4×	31	357
Scott E. Forseen United States	8	81 0.5×	30 0.3×	54 0.7×	28 0.5×	12 0.2×	19	255
W. Bryan Burnette United States	10	141 0.9×	22 0.2×	194 2.4×	40 0.7×	24 0.4×	25	417
Elena Di Martino Sweden	8	57 0.4×	63 0.6×	50 0.6×	102 1.8×	26 0.5×	17	388
Jun‐ichi Nagai Japan	14	58 0.4×	56 0.6×	120 1.5×	35 0.6×	130 2.3×	32	381
Steven Rostad United States	14	36 0.2×	70 0.7×	173 2.1×	46 0.8×	28 0.5×	26	553

Countries citing papers authored by Amanda M. Li

Since Specialization

Citations

This map shows the geographic impact of Amanda M. Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda M. Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda M. Li more than expected).

Fields of papers citing papers by Amanda M. Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amanda M. Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda M. Li. The network helps show where Amanda M. Li may publish in the future.

Co-authorship network of co-authors of Amanda M. Li

This figure shows the co-authorship network connecting the top 25 collaborators of Amanda M. Li. A scholar is included among the top collaborators of Amanda M. Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amanda M. Li. Amanda M. Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Li, Amanda M., Catherine Aftandilian, Susan I. Colace, et al.. (2024). A Retrospective Study of Inotuzumab Ozogamicin in Individuals with Down Syndrome and B-Cell Acute Lymphoblastic Leukemia. Blood. 144(Supplement 1). 4204–4204.

Stukas, Sophie, Kam Shojania, Amanda M. Li, et al.. (2023). Inflammatory Markers in Hemophagocytic Lymphohistiocytosis - a Single Centre Study. Blood. 142(Supplement 1). 5359–5359. 1 indexed citations

Li, Amanda M., et al.. (2023). PB2039: INFLAMMATORY MARKERS IN HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS - A SINGLE CENTRE STUDY. HemaSphere. 7(S3). e499209c–e499209c. 1 indexed citations

Locatelli, Franco, Peter Lang, Selim Corbacioglu, et al.. (2023). Improvements in Health-Related Quality of Life after Exagamglogene Autotemcel in Patients with Transfusion-Dependent Beta-Thalassemia. Blood. 142(Supplement 1). 4997–4997. 1 indexed citations

Rozmus, Jacob, Sima Bhatt, Nataliya P. Buxbaum, et al.. (2022). Is It Possible to Separate the Graft-Versus-Leukemia (GVL) Effect Against B Cell Acute Lymphoblastic Leukemia From Graft-Versus-Host Disease (GVHD) After Hematopoietic Cell Transplant?. Frontiers in Pediatrics. 10. 796994–796994. 3 indexed citations

Annesley, Colleen, Corinne Summers, Michael A. Pulsipher, et al.. (2021). SCRI-CAR19x22v2 T Cell Product Demonstrates Bispecific Activity in B-ALL. Blood. 138(Supplement 1). 470–470. 16 indexed citations

Li, Amanda M., Karen R. Rabin, John A. Kairalla, et al.. (2021). Blinatumomab Associated Seizure Risk in Patients with Down Syndrome and B-Lymphoblastic Leukemia: An Interim Report from Children's Oncology Group (COG) Study AALL1731. Blood. 138(Supplement 1). 2304–2304. 13 indexed citations

Li, Amanda M., Santhosh Thyagu, Dawn Maze, et al.. (2018). Prolonged granulocyte colony stimulating factor use in glycogen storage disease type 1b associated with acute myeloid leukemia and with shortened telomere length. Pediatric Hematology and Oncology. 35(1). 45–51. 32 indexed citations

Li, Amanda M., George Hucks, Amanda M. DiNofia, et al.. (2018). Checkpoint Inhibitors Augment CD19-Directed Chimeric Antigen Receptor (CAR) T Cell Therapy in Relapsed B-Cell Acute Lymphoblastic Leukemia. Blood. 132(Supplement 1). 556–556. 121 indexed citations

10.

Connell, Marisa, Helen Chen, Jihong Jiang, et al.. (2017). HMMR acts in the PLK1-dependent spindle positioning pathway and supports neural development. eLife. 6. 43 indexed citations

11.

Li, Amanda M. & Shahrad R. Rassekh. (2016). Hypotension associated with ingestion of cannabinoids in two children with cancer. Canadian Medical Association Journal. 188(8). 596–597. 8 indexed citations

12.

Li, Amanda M., Christopher Dunham, Uri Tabori, et al.. (2015). EZH2 expression is a prognostic factor in childhood intracranial ependymoma: A Canadian Pediatric Brain Tumor Consortium study. Cancer. 121(9). 1499–1507. 20 indexed citations

13.

Li, Amanda M., Vann Chau, Kenneth J. Poskitt, et al.. (2008). White Matter Injury in Term Newborns With Neonatal Encephalopathy. Pediatric Research. 65(1). 85–89. 88 indexed citations

14.

Froc, David J., et al.. (2003). Reduced Synaptic Plasticity in the Lateral Perforant Path Input to the Dentate Gyrus of Aged C57BL/6 Mice. Journal of Neurophysiology. 90(1). 32–38. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact